Cargando…
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
Plasmodium falciparum malaria causes half a million deaths per year, with up to 9% of this mortality caused by cerebral malaria (CM). One of the major processes contributing to the development of CM is an excess of host inflammatory cytokines. Recently K+ signaling has emerged as an important mediat...
Autores principales: | Hortle, Elinor, Starrs, Lora, Brown, Fiona C., Jane, Stephen M., Curtis, David J., McMorran, Brendan J., Foote, Simon J., Burgio, Gaetan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478876/ https://www.ncbi.nlm.nih.gov/pubmed/31015511 http://dx.doi.org/10.1038/s41598-019-42782-x |
Ejemplares similares
-
Author Correction: KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
por: Hortle, Elinor, et al.
Publicado: (2020) -
New insights into the protective power of platelets in malaria infection
por: McMorran, Brendan J., et al.
Publicado: (2013) -
The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?
por: Lelliott, Patrick M, et al.
Publicado: (2015) -
Genome-wide analysis of chemically induced mutations in mouse in phenotype-driven screens
por: Bauer, Denis C., et al.
Publicado: (2015) -
Ankyrin-1 Gene Exhibits Allelic Heterogeneity in Conferring Protection Against Malaria
por: Huang, Hong Ming, et al.
Publicado: (2017)